News

Opinion
MindSite News on MSN3hOpinion
Therabot Study Flawed and Biased
A psychologist writes to say that our report on a randomized clinical trial for Therabot, an AI therapy chatbot, overlooked methodological weaknesses and researcher bias.
In the first clinical trial of its kind, an A.I. chatbot eased mental health symptoms among participants. The technology may ...
Breakthrough Dartmouth study crystallizes AI's capacity to curate services and spur business innovation. Ten tech readiness ...
Dartmouth's Therabot trial shows promising results for AI-assisted therapy, reducing depression symptoms by 51% and anxiety ...
The evidence-backed model delivered impressive results, but it doesn’t validate the wave of AI therapy bots flooding the market.
Adults showed a significant reduction in their clinical-level mental health symptoms with unrestricted access to a generative ...
Called Therabot, the AI assistant was tested in the form of an app among participants diagnosed with serious mental health problems across the United States. “The improvements in symptoms we ...
Study finds AI chatbot significantly improve symptoms for those suffering from major depressive disorder (MDD), generalized anxiety disorder (GAD), and eating disorders in just two months.
The control group then had access to the smartphone chatbot known as Therabot from week four through to week eight. Unlike chatbots such as ChatGPT, Therabot would initiate engagement with the ...
The randomized clinical trial of Therabot, published in NEJM AI, found that an AI-trained therapy chatbot could play a vital role in expanding access to CBT. A New Frontier in Mental Health Care The ...
The professor discussed the results of his clinical trial that evaluated the effectiveness of “Therabot,” an artificial intelligence psychotherapy chatbot.
Therabot responds to users with natural, open-ended text dialog the researchers developed from current, evidence-based best practices for psychotherapy and cognitive behavioral therapy.